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Abstract
In vivo studies have demonstrated that p63 plays complex and pivotal roles in pluristratified squamous epithelial
development, but its precise function and the nature of the isoform involved remain controversial. Here, we investigate the
role of p63 in epithelial differentiation, using an in vitro ES cell model that mimics the early embryonic steps of epidermal
development. We show that the DNp63 isoform is activated soon after treatment with BMP-4, a morphogen required to
commit differentiating ES cells from a neuroectodermal to an ectodermal cell fate. DNp63 gene expression remains high
during epithelial development. P63 loss of function drastically prevents ectodermal cells to commit to the K5/K14-positive
stratified epithelial pathway while gain of function experiments show that DNp63 allows this commitment. Interestingly,
other epithelial cell fates are not affected, allowing the production of K5/K18-positive epithelial cells. Therefore, our results
demonstrate that DNp63 may be dispensable for some epithelial differentiation, but is necessary for the commitment of ES
cells into K5/K14-positive squamous stratified epithelial cells.
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Introduction
During embryonic development, the body surface is first
covered by a single layer of basal epithelial cells. As development
proceeds, this primitive epithelium switches on a differentiation
program leading to stratification: the ectodermal cytokeratins K8/
K18-positive cells of the primitive epithelium are replaced by basal
epidermal K5/K14-positive cells, and progressively, several layers
of suprabasal differentiated cells appear offering an efficient
resistance against environmental stress. In the adult skin epidermis,
the stratified squamous epithelium maintains a basal layer of
proliferating cells that gives rise to multiple layers of terminally
differentiating cells that continually reach the body surface from
where they are shed. Epidermal stem cells located interfollicularly
and within the bulge region of the hair follicles retain a self-
renewing capacity, critical to preserve the tissue integrity during
the life of the organism. The molecular mechanisms inducing the
stratification program and those regulating the self-renewing
process still remain to be clearly defined.
The p63 transcription factor, a homologue of the tumour
suppressor gene p53 [1], is characterized by six different isoforms
under the control of two distinct promoters and three different
alternative splicings leading to the production of DN- or TA-p63,
and alpha, beta or gamma isoforms, respectively. Recently p63 has
been implicated in both the development and the maintenance of
stratified epithelia [2–4]. In loss-of-function models generated by
two different groups, mice lacking p63 have been shown to be
severely compromised in their ability to generate an epidermis,
many other stratified epithelia as well as the limbs [2,3]. Recent
reports convincingly demonstrated the implication of p63 in
epithelial stem cell renewal potential, as the absence of p63 was
shown to induce a loss of proliferative potential of epidermal [5,6],
corneal [7] or thymic epithelial cells [6,8]. On the other hand,
experiments to complement the absence of p63 during develop-
ment were designed by crossing p63-null mice with transgenic
mice expressing different isoforms of p63 under the control of a
K5-promoter [9]. Those mice expressing TAp63 and DNp63
developed patches of epidermal differentiated cells, but the overall
rescue of the epidermal phenotype remained partial, suggesting an
earlier role of p63 during epidermal morphogenesis, before the
K5-promoter is activated. Accordingly, Koster et. al showed that
the exogenous expression of p63 in single-layered lung K8/K18-
positive epithelial cells was able to initiate a stratification program,
with formation of K14-positive cells [10], suggesting that p63 is
required for the initiation of epidermal stratification, a process
mediated in part by the direct induction of AP-2c expression [11].
However, the precise role of p63 in the morphogenesis of
epidermal cells remains to be defined.
Embryonic stem (ES) cells, derived from blastocyst-stage early
mammalian embryos, are pluripotent and can initiate lineage-
specific differentiation programs of many tissues and cell types in
vitro. ES cells are thus an effective tool in recapitulating in vitro the
main steps of embryonic development. We have recently reported
the efficient derivation of ectodermal and K5/K14-positive
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molecular mechanism of BMP-4 in the neuroectodermal fate [13].
In the present study, we show that the DNp63 isoform is expressed
soon after BMP-4 treatment, along with the simultaneous
expression of direct or indirect p63-target genes associated with
epidermal morphogenesis. Furthermore, p63 knockdown drasti-
cally inhibits the progression of ES cells along the pluristratified
epithelial fate, while de novo expression of p63 is compulsory for
pluristratified epithelial commitment once the ectodermal stage
has been reached. Finally, ectopic expression of DNp63 in ES-
derived ectodermal cells is able to induce their commiment.
Therefore, our results demonstrate that DNp63 is absolutely
necessary at the ectodermal stage for the proper commitment of
ES cells into K5/K14-positive epithelial cells, and therefore
suggest that DNp63 function is required for the embryonic
development of pluristratified squamous epithelia.
Results
DNp63 is expressed during epithelial differentiation of
mouse ES cells
We have previously established a cellular model that recapit-
ulates in vitro, the main steps of embryonic neuroectodermal fate
(Fig. S1). ES cells seeded on a layer of fixed-NIH-3T3 cells in a
serum free medium differentiate into neuroectodermal precursors,
while early mesodermal and endodermal commitments are
inhibited [13,14]. These neuroectodermal precursors have been
shown to further differentiate in 7 to 10 days into neural cell
populations [14,15]. When treated with BMP-4 from day 3 to 5,
the neural differentiation process is efficiently inhibited, partially
through the apoptosis of Sox-1
+ neural precursor cells, as we
recently demonstrated [13], allowing the remaining committed
cells to differentiate into K18-positive ectodermal cells, which are
the putative precursors of epithelial cells. Addition of serum at day
9 allowed keratinocyte differentiation to proceed further [13].
Epidermal differentiation proceeds through successive steps that
lead proliferative keratinocytes, positive for cytokeratins K5 and
K14, to undergo terminal differentiation with the appearance of
specific markers like K1, K10 and involucrin.
During ES cell differentiation, K5/K14-positive epithelial cells
were detected by day 10 /11 and further proliferated into large
patches by day 14 (Fig. 1-A panels a–c). FACS analysis indicated
that, among the differentiated cells, about 10% became epidermal
cellsatday14(Fig.1-B).Theterminaldifferentiationeventsoccured
as K10-positive cells as well as involucrin-positive cells were also
detected by immunofluorescence analysis (Fig. 1-A, panels d,e).
These cellswereinclosecontactto patches of K5/K14-positivecells
(Fig. 1-A, panels d,e) suggesting that the stratification program was
efficiently initiated during ES differentiation. Confocal analysis
clearly confirmed that the differentiated K10-positive cells were
different from the proliferating K14-positive cells (Fig. 1-A, panel f).
Real-time Q-PCR (qRT-PCR) analysis was performed at different
time points: day 5 (48 h after BMP-4 treatment), day 8 (24 h before
serum addition) and day 14 (end of the culture) (Fig. 1-C).
Transcription of the K18, K14 and K5 genes was induced after
BMP-4 treatment (days 5 and 8).Followingserum addition(day 14),
K18 gene expression was reduced while transcription of K5 and
K14 genes were enhanced (Fig. 1-C, panel a). A detailed kinetic
experiment for K18 and K14 gene expression confirmed the
progression along the epithelial developmental process (Fig. S2-A).
The transcription of the three genes encoding laminin-5, the major
adhesion ligand of keratinocytes, was also clearly induced during
this epithelial differentiation process (Fig. 1-C, panel b). At day 14,
specific markers of terminal differentiation of stratified epithelia
(K1, K10, involucrin and filaggrin) were also detected (Fig. 1-C,
panel c). These results indicate that this ES cell model recapitulates
in vitro the stepwise appearance of stratified epidermal cells and is
therefore suitable to study the function of p63 isoforms during
embryonic epithelial cell differentiation.
DNp63 transcripts were detected after BMP-4 addition at day 5
and remained high during ES differentiation (Fig. 2-A and Fig. S2-
B). TAp63 was never detected during epidermal commitment. By
Western blot, DNp63 was detectable at days 9, 11 and 14 (Fig. 2-B
and Fig. S2-C). In accordance with the qRT-PCR analysis, TAp63
protein was never detected during ES differentiation. Several non
specific bands, which are characteristic of the pan-p63 antibody
used in this study, were observed but their migration rates did not
correspond to any p63 isoform (Fig. 2-B and Fig. S2-C).
Of note, DNp63 isoform was detected by Western blot analysis
much later (day 9) than its transcript (day 5), probably due to the
heterogeneity of the cellpopulation and the difference of sensitivity of
the two methods. Therefore, we evaluated p63 detection at the
cellular level by immunofluorescence staining. In the absence of
BMP-4, no DNp63 expression could be observed at any time point.
In the presence of BMP-4, nuclear-stained DNp63-positive cells
became detectable among K18-positive ectodermal cells by immu-
nofluorescence staining at day 7 (Fig. 2-C). Further addition of serum
allowed DNp63-positive cells to differentiate into K14
+/K5
+
keratinocytes, all K14-positive cells being then DNp63-positive
(Fig. 2-C). At day 14, large patches of K14/K5/DNp63-positive
cells were observed. It should be noted that not all DNp63-positive
cells were positively stained for K14, while all K14
+ cells expressed
DNp63 (Fig. 2-C) It suggests that these DNp63-positive cells were not
yet committed into the keratinocyte lineage, or that part of them were
already committed to alternative epithelial fates. Finally, we were not
able to detect TAp63-positive cells using a specific antibody,
confirming the absence of TAp63 transcripts (data not shown).
DNp63 expression is required for the commitment of
mouse ES cells into keratinocytes
To evaluate whether DNp63 was required for stratified epithelial
commitment, stable ES cell clones that express a small hairpin (sh)
RNAinhibitingp63expressionwereproduced.AsshowninFig.3A,
two independent ES cell clones (sh-p63-cl1 and sh-p63-cl2)
displayed, by Western-blot analysis, a strong inhibition of
exogenously expressed DNp63, which was not observed with the
sh-control clone. Upon differentiation with BMP-4 and serum, the
sh-p63 clones produced, at day 14, a number of ectodermal K18-
positive cells similar to the wild type control cells (Fig. S3-A, B). It
confirmed that the ectodermal differentiation of ES cells was
independent of the expression of DNp63. However, while large
patches of K14-positive cells were observed within the sh-control
clone (Fig. 3-B), very few isolated K14-positive cells were detected
with sh-p63-cl1 and sh-p63-cl2 clones at day 14. Analysis by FACS
confirmed that the absence of DNp63 resulted in a strong reduction
of K14 and K5-expressing cells at day 14 (Fig. 3-C). At the
transcriptional level, we further confirmed the strong inhibition of
the K14 mRNA level in differentiating sh-p63-ES clones (Fig. 3-D).
Accordingly, lama3 gene expression, as well as terminal differen-
tiation markers such as K1, K10, involucrin and filaggrin were
completely repressed when p63 was knocked down (Fig. 3E). The
two other genes encoding for laminin-5 (lamb3 and lamc2) were
repressed as well in sh-p63 ES cells (data not shown). Interestingly,
while K14 expression was drastically reduced, the expression of K5
mRNA was not modulated by the absence of DNp63 and a
significant percentage of K5-positive cells was still observed by
FACS analysis (Fig. 3-C) with the two sh-p63-ES clones (5.6% and
5.7%, respectively), as compared to sh-control and wt-ES cells
p63 in Epidermal Fate
PLoS ONE | www.plosone.org 2 October 2008 | Volume 3 | Issue 10 | e3441Figure 1. Epidermal differentiation of murine ES cells. (A) Appearance of K5
+/K14
+ and involucrin-positive epidermal cells from mouse ES cells
treated with BMP-4 and serum. The differentiated cells were immunostained for cytokeratin K14, K5, K10 or involucrin at day 14 (panels a–e). Scale
bars=50 mm. Confocal analysis of differentiated cells (at day 14) (panel f). (B) Flow cytofluorimetry analysis of K5 and K14 on differentiated cells at day
14 of culture. The graphs represent the fluorescence intensity for the indicated proteins plotted against the cell size (forward scatter, FSC). The
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cells were not able to produce keratinocytes and accordingly we
could no longer observe the patches of K14/K5-positive cells
obtained during the differentiation of control ES cells (Fig. 3-B).
Instead, the K5-positive cells, orphans of K14, were systematically
detected within structures of rounded flat clones still positive for the
Figure 2. Expression of DNp63 during epidermal differentiation of murine ES cells. (A) Real-time RT-PCR analysis for DN- and TA-p63
isoform gene expression at the indicated differentiation time points. The value for each gene was normalized to untreated control ES cultures, and
represents the average of three independent experiments6sd. (B) Immunoblots of endogenous p63 isoforms in normal mouse keratinocytes (NMK),
myocytes and ES cells during 3, 5, 9, 11 and 14 days of differentiation, as revealed by anti-p63 and anti-Erk2 (as loading control) antibodies. Normal
mouse keratinocytes (known to express endogenous DNp63 isoforms) and differentiating myocytes (which have been shown to express the TAp63
isoform, [24]) served as molecular weight references. (C) Immunofluorescence detection of DNp63 during ES cell differentiation. The differentiating
cells were immunostained for K18 or K14 (green) and for DNp63 (red). Dapi staining is shown in blue. Scale bars=50 mm.
doi:10.1371/journal.pone.0003441.g002
percentages of positive cells among the gated populations are indicated on graphs. (C) Gene expression was analyzed by real-time RT-PCR, for K18,
K5, and K14 at the indicated differentiation time points (panel a), for laminin-5 chains at day 14 (panel b), and for K1, K10, filaggrin and involucrin at
day 14 (panel c). The value for each gene was normalized to untreated control ES cultures, and represents the average of three independent
experiments6sd.
doi:10.1371/journal.pone.0003441.g001
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was also detectable within wt and sh-control ES cell differentiation
along with the large K14/K5-positive patches. Since they were
detected as early as day 11 and still present at the end of the culture
(up to day 17), they may represent alternative epithelial cells.
Activation of p63-regulated or-dependent genes during
epidermal differentiation
Recently, several genes dependent on p63 expression and
associated with the murine early embryonic epidermal morpho-
genesis have been identified [16–18]. Among them, BMP-7,
FGFR2b, Notch1 and Jagged1 transcripts have been shown to be
absent from the developing epidermis of p63-deficient mice [18].
IKKa and GATA3 are two other genes regulated by p63 and
associated with epidermal development [16,19,20]. Finally, Perp, a
protein promoting the stable assembly of desmosomal adhesive
complexes, was one of the first described p63 regulated proteins
implicated in epidermal development [17]. We thus monitored
their expression during ES epidermal differentiation as compared
to undifferentiated ES cells. Upon BMP-4 treatment, in parallel to
the induction of DNp63 gene expression, all the transcripts were
Figure 3. p63 is required for epithelial differentiation of ES cells. Stable ES cell clones in which DNp63 gene expression has been inhibited
with shRNA, were produced and induced to differentiate into the epidermal fate. (A) Analysis of ES clones transfected with a control pSuper sh-RNA
(ctrl) or a pSuper sh-RNA specific for p63 (clones sh-1, sh-2). Wild type ES cells and stable clones were transiently transfected with a DNp63-expressing
vector and analyzed 48 h later by Western blot with anti-DNp63 and anti-Erk2 (as loading control) antibodies. The two p63 sh-RNA clones displayed a
strong inhibition of the ectopic DNp63 expression while the pSuper control was unable to regulate it. (B) Immunofluorescence staining for the
indicated proteins in control and sh-p63 ES cell clones at day 14 of differentiation. Dapi staining is shown in blue. Bars=50 mm. (C) Percentages of
K14- or K5-positive cells differentiating from wt-ES cells, control-sh or p63-specific sh ES clones at day 14 determined by flow cytofluorometric
analysis. (D) Real-time RT-PCR analysis at day 14 of differentiation for DNp63, K5, K14 and Lama3 (left panel) and for K1, K10, filaggrin and involucrin
(right panel) genes. ES cell clones expressing either a control- or p63-specific shRNA were tested.
doi:10.1371/journal.pone.0003441.g003
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some of them (2–5 fold) as compared to the very pronounced
induction of DNp63 (100 fold) reflected that DNp63 was not
expressed at all before BMP-4 treatment (.35 cycles of qPCR)
while mRNA of these genes were already detected before (22–25
cycles). To demonstrate that p63 is directly responsible for at least
part of this modulation, the expression of potential p63-target
genes were tested at day 14 in sh-63-cl2 ES cells as compared to
control ES cells. Absence of p63 drastically reduced the expression
of each gene during epidermal commitment, with the exception of
BMP-7, which could be activated by an alternative mechanism,
independent of the epidermal commitment (Fig. 4B). Similar
results were obtained with the second sh-p63-cl1 (data not shown).
We can conclude that the present model of ES-derived stratified
epithelium commitment faithfully recapitulates molecular events
known to be essential in epidermal morphogenesis.
Exogenous expression of DNp63 does not allow the
production of K14-positive cells in absence of BMP-4 and
serum
Since DNp63 expression was detected at day 7, before the
appearance of K14-positive cells, we evaluated whether exogenous
expression of DNp63 could, in the absence of a BMP-4 dependent
signalling pathway, induce keratinocyte commitment. ES cells
were transduced, at day 4 of differentiation, with a lentiviral vector
expressing DNp63. At days 8 and 14, expression of keratinocyte-
specific gene was barely detected after infection with DNp63-
lentivirus, as compared to cells cultivated in the presence of BMP-
4 and serum (Fig. 5A). Careful systematic counting of large areas
under the microscope detected very few K14
+ cells (data not
shown). Thus, DNp63 is not able to induce keratinocyte
differentiation in absence of BMP-4. To define if DNp63 can
synergize the effect of BMP-4, a DNp63-expressing construct was
stably inserted into ES cells which were induced to differentiate
with and without BMP-4. As illustrated in Fig. 5B, no
enhancement of K14
+ or K5
+ cell production was detected by
qRT-PCR when the ES cells were treated with both BMP-4 and
DNp63 as compared to BMP-4 alone. Furthermore, infection of
ES cells with a lentivirus expressing DNp63 at day 4 of
differentiation did not enhance the effect of BMP-4 on
keratinocyte production (data not shown). Since we previously
have shown that BMP-4 efficiently induces ES cell to differentiate
into ectodermal K8
+/K18
+ cells ([13] and Fig. S2-A), it suggested
that DNp63 can induce epidermal commitment only in ES-derived
cells that already have received and integrated ectodermal signals
delivered by BMP-4.
Figure 4. Time course of relative mRNA expression of several
p63-regulated genes. (A) Real-time RT-PCR analysis for p63-targets
genes at 3 differentiation time points, normalized to untreated control
ES cultures. The data represents the average of three independent
experiments6sd. (B) Relative mRNA expression for different p63-
regulated genes. (A) Real-time RT-PCR analysis for p63-target genes at
3 differentiation time points, normalized to undifferentiated ES cells at
day 0. (B) Real-time RT-PCR analysis for p63-target genes in control and
sh-p63 cl2 ES cells at day 14 normalized to undifferentiated WT ES cells
at day. The data represents the average of three experiments6sd.
doi:10.1371/journal.pone.0003441.g004
Figure 5. Ectopic expression of DNp63 does not induce
efficient stratified epithelial commitment of ES cells. (A)
Differentiating ES cells were either treated with BMP-4 (at day 3) or
transduced (at day 4) with lentiviruses expressing either DNp63 or
irrelevant proteins (red tomato or Pax6) as negative controls. Real-time
RT-PCR analysis for K5, K14 and laminin-5 gene expression was
performed at days 5, 8 and 14 of ES cell differentiation. The value for
each gene was normalized to either untreated control cultures for BMP-
4-treated ES cells or red tomato transduced control cultures for p63-
transduced ES cells. The values represent an average of three
determinations6sd. (B) Wild type ES or ES cells stably expressing
DNp63 were induced to differentiate with and without BMP-4. Real-time
RT-PCR analysis for K5, K14 and p63 gene expression was performed at
day 14. The value for each gene was normalized to untreated wild type
ES cells at day 14. The values represent an average of three
determinations6sd.
doi:10.1371/journal.pone.0003441.g005
p63 in Epidermal Fate
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to differentiate into keratinocytes
To further demonstrate that DNp63 is potent to induce
ectodermal precursors to become keratinocytes, we isolated by
serial dilution of BMP-4-treated ES cells at day 7, a homogenous
ectodermal cell line positive for K8/K18 cytokeratins [25].
Exogenous expression of DNp63 in this ectodermal cell line indeed
induced the differentiation of DNp63-transduced cells into K14-
positive cells (Fig. 6-A and B). None of the control-transduced cells
expressed the keratinocyte-specific genes (Fig. 6-B). Since not all
(about 25–40%) of the ectodermal cells expressing de novo DNp63
became K14
+-cells, we hypothesized that the ES-derived ectoder-
mal K18
+ cell population could be heterogeneous in its response to
p63. To test if p63 still remains able to transactivate in these
unresponsive cells, the ES-derived ectodermal cell line was
cotransfected with DNp63 and a p63-responsive reporter construct
[26]. 48 h after transfection, cells were analyzed by immunofluo-
rescence staining for tagged-p63, luciferase and K14 gene
expression (Fig. 6C). Interestingly, although not all the p63-
transfected cells became K14
+ keratinocytes, they all expressed
luciferase, strongly suggesting that the K18
+ ectodermal cells unable
to become K14
+ cells are locked by an unknown mechanism.
Further studies will be necessary to identify the molecular
differences between cells belonging to this apparent homogenous
ectodermal cell population. Finally, p63-target genes were also
induced upon ectopic expressionof DNp63 (not shown, Rostagno et
al, in preparation). Altogether, these results indicate that DNp63 is
necessary to switch-on the differentiation program of pre-commit-
ted ectodermal cells into K14-positive epithelial cells.
Discussion
The ability of ES cells to remain pluripotent and to differentiate
in vitro in directed or selected cell fates, depending on culture
conditions, make them a powerful tool to investigate in vitro
molecular events involved in embryonic development. Here, we
demonstrated that DNp63 is a key factor necessary for embryonic
epidermal differentiation. In absence of p63, committed ectoder-
mal cells are not able to produce neither proliferating (K14
+/K5
+)
nor terminally differentiated (K1
+/K10
+) keratinocytes. The
implication of p63 in pluristratified epithelia morphogenesis/
maintenance in mice was revealed by the severe phenotype of p63-
deficient mice, born with a defect in all pluristratified epithelia
[2,3]. Nevertheless, a key question remained regarding the precise
role of p63 in such epithelial developments. Indeed, the presence
of uncommitted, single layered, primitive ectodermal cells
covering the body surface of p63-deficient mice suggested that
the p63-null phenotype leads to an absence of progression along
the epidermal lineage with an early block in the epithelial
stratification program [2,10]. In that case, the expression of p63
must occur very early during epidermal development before the
stratification program will commit ectodermal cells into epidermal
cells, as already suggested by Koster and Roop [10]. Accordingly,
in our cell model, the expression of the DNp63 isoform occurred
very early along the development pathway, soon after the
ectodermal cell fate was induced by BMP-4 treatment and prior
to the formation of K14
+/K5
+ cells. Interestingly, modulation of
DNp63 expression in zebrafish embryos has demonstrated its role
in early dorsal/ventral ectodermal patterning as well as neural/
epidermal specification: in vivo inhibition of p63 was shown to
prevent skin formation, while its exogenous expression promoted
epidermal specification [21,22]. Furthermore, it has been recently
reported that in an organotypic reconstitution assay, p63-
knockdown keratinocytes dedifferentiated toward an ectodermal
fate, as they expressed de novo K8/K18 genes, and became unable
to stratify [23]. Moreover, ectopic expression of p63 was shown to
be able to initiate a stratification program in single-lung epithelia,
as demonstrated by histological and molecular analyses [10]. All
this strengthens the notion that K14
+/K5
+ epithelial cells can only
be produced when DNp63 is expressed, as clearly demonstrated in
the present study.
On the other hand, clumps of terminal-differentiated cells in
epidermis of p63-deficient mice were observed by McKeon et al.
[3,6,9]. Thus, the authors suggested that the phenotype of these
mice was not due to a default in embryonic epidermal
differentiation but resulted from the inability of the epithelial
stem cells to self renew. Accordingly, they recently demonstrated
that DNp63 is required for adult epithelial stem cells to maintain
their proliferative potential [6]. We believe that, instead of a
contradiction, our data along with those described by Roop’s
team, strongly support a dual function for DNp63 during
embryonic epidermal fate and in epithelial homeostasis. Indeed,
Figure 6. ES-derived ectodermal cells differentiate into K14/K5-
positive epidermal cells upon DNp63 ectopic expression. An
ectodermal K8
+/K18
+ cell line was derived by serial clonal dilutions of
differentiating ES cells after BMP-4 treatment. (A) Immunofluorescence
staining of the ES-derived ectodermal cell line 48 h after infection with
a lentivirus expressing c-myc-tagged-DNp63. Control cells were
transduced with a control c-myc-tagged-pax6 lentivirus. Nuclei are
stained with DAPI. Bars=50 mm. (B) Percentages of K14-positive cells
amongst transduced cells 48 h after infection, as determined by
immunofluorescence staining of c-myc and K14-positive cells. (C)
Immunofluorescence staining of the ES-derived ectodermal cell line
48 h after cotransfection of c-myc-tagged-DNp63 and a p63-responsive
reporter luciferase construct. Positive cells were detected with c-myc
and luciferase antibodies. Nuclei are stained with DAPI. Bars=50 mm.
doi:10.1371/journal.pone.0003441.g006
p63 in Epidermal Fate
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embryonic commitment of thymic epithelial cells is not affected in
p63-deficient mice [6,8]. Furthermore, these thymic p63-deficient
epithelial cells do not express K14
+/K5
+ but K5
+/K18
+ and
cannot therefore be considered as equivalent of epidermal stem
cells. It suggests that mechanisms, in addition to the proliferative
capability, are affected by the absence of p63 in order to explain
the lack of K5
+/K14
+ epidermal cells in our in vitro model, as well
as in vivo in p63-null mice.
Finally, we observed in absence of p63, the presence of
structures composed of epithelial cells positive for K5 and K18.
Interestingly, as for thymic K5
+/K8
+ epithelial cell commitment
shown in p63-deficient mice [6], the differentiation of these ES-
derived K18/K5-positive cells was not inhibited by the absence of
p63. Altogether, these and our results suggest that epithelial
lineages are differently affected by the absence of p63 during their
morphogenesis. Distinct functions that might be activated
sequentially during embryogenesis and the adult life span can
then be attributed to p63. It is clear that p63 will have a major
contribution in epithelial cell development through its regulatory
impact on stem cell proliferative potential [6]. But it also appears
that p63 may contribute to the required molecular steps implicated
in other epithelial cell commitments, a role which is in accordance
with the severe phenotype described for the p63-deficient mice. In
this regard, we propose that, during embryogenesis, the ectoder-
mal inducing phase (triggered by BMP-4 in our system) must
include, as a necessary step, the expression of DNp63 to allow
pluristratified epithelial cell fate to occur.
Materials and Methods
Cell culture and neuro-ectodermal differentiation
The mouse ES cell line CGR8 and derived clones were
maintained as previously described [13]. Briefly, the ES cells were
routinely cultured in flasks coated with PBS 0.1% gelatin, in
GMEM medium (Gibco BRL, Invitrogen, Cercy-Pontoise,
France) supplemented with 10% FCS (FCIII, Perbio-Hyclone,
Bezons, France), 1 mM non-essential amino acids, 1 mM Sodium
Pyruvate, 0.1 mM ß-mercaptoethanol and 10
3 U/ml LIF (Leu-
kemia Inhibitory Factor, our own production), and passaged every
2 days. The ES-derived ectodermal cell line was routinely cultured
in DMEM medium (Gibco BRL) supplemented with 10% FCS
(FCII, Hyclone) and 0.1 mM bME, and passaged every 2 days.
For the differentiation protocol, NIH-3T3 cells were grown to
confluency in DMEM 10% FCS, they were fixed with PBS 3%
formaldehyde (Sigma-Aldrich, France) for 15 min, washed with
PBS and incubated with glycine (1 mM) (ICN Pharmaceuticals,
France) for 15 min to saturate free formaldehyde sites. Dishes or
coverslips were stored in PBS at 4uC until used for ES cell
differentiation. For neuro-ectodermal differentiation, ES cells were
cultured on fixed NIH-3T3 cells for 9 days in ES cell culture
medium in which serum was replaced with 10% Knock-out Serum
Replacement (KSR) (Gibco BRL). At day 9 and till day 14, the
differentiation medium (10% KSR) was replaced by the ES cell
culture medium (10% FCS, without LIF addition). When
indicated, 0.5 nM human recombinant BMP-4 (R&D Systems
Europe, UK) was added to the differentiation medium each day
from day 3 to day 5.
Antibodies and immunofluorescence
Cells were fixed in methanol at 220uC for 15 min, incubated
with PBS containing 2.5% bovine serum albumin (BSA) (Sigma-
Aldrich) and 2.5% normal donkey serum (Jackson Immunore-
search) for 30 min and stained as already described [13]. The
primary antibodies used for immunofluorescence were: rabbit anti-
DNp63 (Poly6190, Biolegend, Ozyme, France), rabbit anti-mouse
K5 (PRB-160P, Babco, Covance, USA), rabbit anti-mouse K14
(PRB-155P, Babco), rabbit anti-mouse K10 (PRB-159P, Covance),
rabbit anti-involucrin (PRB-140C-0200, Covance, Eurogentec,
Belgium), rabbit anti-luciferase (AB-21176, Abcam) and rabbit
anti-Pax-6 (Abcyss, Paris, France); monoclonal anti-mouse K14
(NE12 8EW, Novocastra Laboratories Ltd), anti-mouse K18 (MAB
3234, Millipore, France), anti-Flag C-myc (9E10, Santa Cruz
Biotechnology, Tebu International, France). Secondary Alexa-488
and Alexa-594 donkey anti-mouse and anti-rabbit antibodies were
purchased from Molecular Probes (Invitrogen).
Real-time quantitative RT-PCR
RNAs were extracted using Trizol reagent (Invitrogen) and
incubated with DNase I (Ambion, France), according to the
manufacturer’s instructions to minimize genomic DNA contam-
ination. cDNAs were synthesized using the Superscript II Reverse
Transcriptase (Invitrogen). The relative expression level of
transcripts was quantified by q-real time-PCR using the Power
SYBR-Green PCR Master Mix (Perkin Elmer Applied Biosystems,
France) on an ABI PRISM 7500 Sequence Detection System,
according to the manufacturer’s instructions. The expression of
each gene was determined relative to 36B4 as an internal control
and the fold stimulation was calculated by using the equation
(2)
2DDCT, where DDCT=CT gene – CT 36B4 and DDCT=DCT
stimulated condition – DCT unstimulated condition. Each gene
was amplified using the appropriate specific primers.
36B4: 59-TCCAGGCTTTGGGCATCA-39 59-CTTTATCAGCTGCACATCACTCAGA-39
BMP-2: 59-TCAAGCCAAACACAAACAGC-39 59-ACCCCACATCACTGAAGTCC-39
BMP-7: 59-GGAAAAATGTCTGCCAGGAA-39 59-AGGCTTGCGATTACTCCTCA-39
DNp63: 59-TGTACCTGGAAAACAATGCCCA-39 59-GACGAGGAGCCGTTCTGAATCT-39
FGRF2b: 59-CACCAACTGCACCAATGAAC-39 59-TGCTTGAATGTGGGTCTCTG-39
GATA3: 59-CCGAAACCGGAAGATGTCTA-39 59-GTTGAAGGAGCTGCTCTTGG-39
IKKa: 59-GGAAAGTATGGGCTGAAGCA-39 59-CTGCTCTTTGTCCCTGGAAG-39
Involucrin: 59-CACAATGCCAGGTCTTCACTGA-39 59-AGGGTTTGGCCGCTTCTC-39
Jagged 1: 59-TCTCTGACCCCTGCCATAAC-39 59-CAGCCTGGAGAACACTCACA-39
K1: 59-AACCCGGACCCAAAACTTAG-39 59-CCGTGACTGGTCACTCTTCA-39
K10: 59-GACAACTGACAATGCCAACG-39 59-CAGGGTCACCTCATTCTCGT-39
K14: 59-AAGGTCATGGATGTGCACGAT-39 59-CAGCATGTAGCAGCTTTAGTTCTTG-39
K5: 59-CCTGCAGAAGGCCAAGCA-39 59-TGGTGTTCATGAGCTCCTGGTA-39
K18: 59-AATCGAGGCACTCAAGGAAGAA-39 59-GGCATCCACTTCCACAGTCA-39
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The lentiviral vector production was performed using 293-FT
producing cells, cultured in 10% FCS DMEM medium on
collagen matrix, and transfected in Lipofectamine 2000 with the
plasmids required for the lentivirus production (MD2G, 8.93, 8.92
vectors) and expression plasmids for c-myc-tagged-DNp63, Pax6
or red-tomato fluorescent protein. On the day following
transfection, DMEM medium was replaced with Opti-MEM
supplemented with 25 mM Hepes, 0.1 mM Non Essential Amino
acids and 1 mM Sodium Pyruvate. Forty-eight later, the
supernatants were collected and concentrated using Centricon
Plus-20 columns (Millipore).
Plasmid DNA Transfection: Generation of stable ES Shp63
clones
Plasmid pSuper vectors containing short-hairpin (sh) p63 or
control sequence were kindly provided by C. Missero (CEINGE
Biotecnologie Avanzate Scarl, Napoli). A plasmid c-myc-tagged-
DNp63 vector was kindly provided by H. Van Bohkoven
(Nijmegen, Netherlands). Undifferentiated ES cells (passage 25)
were transfected with Lipofectamine 2000 (Invitrogen) according
to the manufacturer instructions. Twenty-four hours later,
transfected ES cells were passaged and treated 12 hours later
with puromycin for 15 days. Resistant ES stable clones were
isolated and cultured separately in the presence of puromycin
(1 mg/ml). Isolated clones were tested by immunoblotting with
anti-DNp63, either for expression of DNp63 (ES cell stably
expressing DNp63) or for expression of the sh-p63 after
transfection with the c-myc-tagged-DNp63 expression vector.
FACS analysis
FACS analysis was performed as previously described [13] with
anti-mouse K14 (NE12 8EW) or K5 (PRB-160P) antibodies.
Briefly, ES cells cultured on fixed NIH-3T3 cells were detached
with trypsin 0.5 mM EDTA. They were fixed in 2% formaldehyde
in PBS, permeabilized in PBS-0.5% saponin (Sigma-Aldrich)-0.5%
BSA for 10 min and saturated with PBS-0.5% saponin-0.5% BSA-
0.5% rabbit or swine serum depending on secondary antibodies
for 30 min. The ES cells were stained with primary mAbs for
45 min. Mouse isotype control mAb (PharMingen) and control
rabbit serum was used to set the background level of fluorescence.
Rabbit anti-mouse and swine anti-rabbit coupled FITC antibodies
(Dakko A/S, country) were added for 45 min. Cells were
monitored by flow cytofluorimetry on a FACScan system using
CellQuest software (BD Biosciences).
Immunoblotting analysis
HeLa cells were cultured in 60 mm dishes and transfected with
TAp63 (a, b, c) and DNp63 (a, b, c) expressing vectors, and lysed
24 hours later in buffer containing 25 mMTris HCl pH 7.6,
150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 1% SDS.
Differentiating ES cells were lysed at different time points in the
same buffer. Undifferentiated ES cells were cultured in 60 mm
dishes, transfected with DNp63-c-myc-tag expressing vector, and
lysed 48 h later in buffer containing 50 mM Tris pH 7.4, 150 mM
NaCl, 1% Triton X-100, 10 mM leupeptin, 1 mM AEBSF, 100
units/ml aprotinin, 10 mM NaF and 1 mM Na3VO4. Samples
(30 mg of proteins) were resolved by 12% SDS-PAGE, transferred
to Hybond C Extra nitrocellulose membranes (Amersham
Biosciences, France), and then incubated with the appropriate
antibodies: mouse monoclonal antibody raised against p63 (4A4,
Sc-8431, Santa Cruz Biotechnology, Tebu International), mouse
monoclonal IgG2b antibody raised against Erk-2 (Sc-1647, Santa
Cruz Biotechnology, Tebu International) and rabbit polyclonal
antibodies raised against DNp63 (Poly6190). Proteins were
visualized with the ECL system (Amersham) using HRP-
conjugated anti-rabbit or anti-mouse secondary antibodies.
Supporting Information
Figure S1 Schematic graph representing the ES cell differenti-
ation protocol used in this study. Mouse ES cells were seeded in
culture on NIH-3T3-PFA-fixed cells in serum-free medium for 14
days, with change of medium every 2 to 3 days. (A) In the absence
of BMP-4 treatment, ES cells differentiate exclusively into neural
cell populations. (B) Treatment with BMP-4 from day 3 to day 5
inhibits neural cell fate and induces K18-positive ectodermal cell
differentiation. When serum is added at day 9, ectodermal cells
differentiate further into epithelial cells expressing K5 and K14
basal squamous stratified epithelium markers, as well as K1 and
K10 terminal differentiation markers.
Found at: doi:10.1371/journal.pone.0003441.s001 (1.86 MB TIF)
Figure S2 DNp63 expression during ES cell differentiation. (A)
Time course expression of K18 and K14 genes. Relative K18 and
K14 gene expression levels were determined by real-time RT-
PCR at the indicated time points during the ES cell differentiation.
The value for each gene was normalized to the untreated control
cells at day 1. (B) Percentages of K18-positive cells obtained at day
7 and 14 from ES cell cultures treated or not with BMP-4 as
determined by flowcytometric analysis. (C) Time course expression
of DNp63 and 36B4 genes. The graph represents the Ct values for
real-time RT-PCR analysis of the DNp63 and the 36B4 (control)
mRNA expression at the indicated time points during the ES cell
differentiation and from 3T3 fibroblasts and NMK. This graph
displays one representative experiment out of three. (D) Proteins
extracted from HeLa cells transfected with p63 isoforms, NMK
and myocytes were immunoblotted with anti-p63 and anti-Erk2
(as loading control) antibodies. NMK (known to express
endogenous DNp63 isoforms) and differentiating myocytes (which
have been shown to express the TAp63 isoform, [24]) served as
molecular weight references.
Found at: doi:10.1371/journal.pone.0003441.s002 (2.05 MB TIF)
Figure S3 The ectodermal differentiation is not affected by the
absence of p63.(A) Immunofluorescence staining (left panel) for
K18 at day 14 of differentiation (BMP-4 and serum treatments) in
control- and p63-sh ES cell clones. Bars=50 mm. (B) Real-time
Filaggrin: 59-CTGTTCCTGCAATAGGACTGAC-39 59-TGCTGAAGAAAGGGCAGA-39
Lam A3: 59-CTGCCACCCTCAGTTCACAGT-39 59-CGCCGTACGATGATACCTTATCA-39
Lam B3: 59-AAGACCCTTCAGGAGCCTTC-39 59-TGGCTCAGCAGGCTAGAACT-39
Lam C2: 59-GGCCCTTCGAGACATTCTAA-39 59-GTCGTTCTCTTGGCTCCTTG-39
Notch1: 59-GCAATCTCAAGTCTGCCACA-39 59-GCTTCCTTGCTACCACAAGC-39
Perp: 59-GGATGGGAGGATGGACTAGG-39 59-GTGACAGTGGTGACCCTCCT-39
TAp63: 59-TGGATGAACCTTCCGAAAATG-39 59-TGCGGATACAATCAATGCTAAT-39
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and serum) of differentiation for K18 gene expression from ES cell
clones expressing either a control- or p63- shRNA. The values
were normalized to untreated control cultures and represent the
average of three experiments6sd.
Found at: doi:10.1371/journal.pone.0003441.s003 (3.62 MB TIF)
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